NASDAQ:SRNE
Delisted
Sorrento Therapeutics Stock News
$0.307
+0 (+0%)
At Close: Feb 23, 2023
Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors
06:04pm, Tuesday, 05'th Jul 2022 GlobeNewswire Inc.
PALO ALTO, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “S
Hot Penny Stocks to Buy This Week? 3 to Watch Right Now
05:13pm, Tuesday, 05'th Jul 2022
Are these penny stocks worth buying right now? The post Hot Penny Stocks to Buy This Week?
Why Sorrento Therapeutics Stock Is Jumping Today
03:32pm, Tuesday, 05'th Jul 2022 The Motley Fool
The biotech's bargain-basement valuation appears to be attracting investors' interest.
Why Sorrento Therapeutics Stock Is Jumping Today
11:32am, Tuesday, 05'th Jul 2022
The biotech's bargain-basement valuation appears to be attracting investors' interest.
Best Penny Stocks To Watch? 4 For Your Independence Day List
07:04pm, Friday, 01'st Jul 2022 PennyStocks
Penny stocks to watch right now
The post Best Penny Stocks To Watch? 4 For Your Independence Day List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Watch? 4 For Your Independence Day List
03:04pm, Friday, 01'st Jul 2022
Penny stocks to watch right now The post Best Penny Stocks To Watch? 4 For Your Independence Day List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Epizyme + 20 Stocks Moving In Monday's Pre-Market Session
10:31am, Monday, 27'th Jun 2022 Benzinga
Gainers
Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday.
Epizyme, Inc. (NASDAQ: EPZM) rose 57.2% to $1.50 in pre-market tradi
Sorrento Therapeutics, Inc. announces the appointment of the Honorable Tommy G. Thompson, as Covid-19 Special Consultant to Chairman and CEO Henry Ji
07:38pm, Friday, 24'th Jun 2022 GlobeNewswire Inc.
SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a commercial and clinical-stage biopharmaceutical company dedicated to developing and commerc
Looking For the Best Penny Stocks to Buy? 3 to Watch
08:16pm, Wednesday, 22'nd Jun 2022 PennyStocks
Which penny stocks are you watching right now?
The post Looking For the Best Penny Stocks to Buy? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Looking For the Best Penny Stocks to Buy? 3 to Watch
04:16pm, Wednesday, 22'nd Jun 2022
Which penny stocks are you watching right now? The post Looking For the Best Penny Stocks to Buy?
Scilex Holding Company, a Sorrento Company, enters into an agreement for an exclusive license with ROMEG Therapeutics, LLC, for the right to commercialize Gloperba®, an FDA-approved prophylactic treatment for painful gout flares in adults, in the US.
02:33pm, Tuesday, 14'th Jun 2022 GlobeNewswire Inc.
PALO ALTO, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “S
SAN DIEGO, June 03, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced the first subject was dosed in a Phase I clinical study (NCT05364840) of its oral
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured Notes
01:00pm, Friday, 03'rd Jun 2022 GlobeNewswire Inc.
SAN DIEGO and PALO ALTO, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasd
Immatics (IMTX) Lags Q1 Earnings and Revenue Estimates
12:25pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
Immatics (IMTX) delivered earnings and revenue surprises of -18.28% and 23.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. and Levena Biopharma, a Sorrento Company, are to Present Positive Clinical Progress of A166, an Anti-HER2 ADC, in Treating Locally Advanced or Metastatic HER2-Positive Breast Cancer Patients at the ASCO 2022 Annual Meeting
09:00am, Wednesday, 01'st Jun 2022
CHENGDU, China, and SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Sichuan Kelun-Biotech Biopharmaceutical Co, Ltd. ("Kelun-Biotech") and Levena Biopharma (“Levena”), a subsidiary of Sorrento Thera
